OPCH · Option Care Health, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $5.65B | $5.00B | $4.30B | $3.94B | $3.44B | $3.03B |
| Cost of Revenue | $4.56B | $3.45B | $3.32B | $3.08B | $2.66B | $2.35B |
| Gross Profit | $1.09B | $1.01B | $981.22M | $866.92M | $779.61M | $682.26M |
| R&D | - | - | - | - | - | - |
| SG&A | $682.45M | $630.25M | $607.43M | $566.12M | $525.71M | $500.20M |
| Total Operating Expenses | $749.99M | $691.16M | $666.63M | $626.69M | $588.76M | $571.51M |
| D&A | $67.54M | $60.91M | $59.20M | $60.56M | $63.06M | $71.31M |
| Operating Income | $337.91M | $321.83M | $314.60M | $240.23M | $190.84M | $110.75M |
| Interest Expense | $54.56M | $49.03M | $51.25M | $53.81M | $67.00M | $107.77M |
| Income Tax | $75.31M | $71.78M | $91.65M | $55.21M | ($23.40M) | $2.83M |
| Net Income | $207.59M | $211.82M | $267.09M | $150.56M | $139.90M | ($8.08M) |
| EPS - Basic | $1.28 | $1.23 | $1.49 | $0.83 | ($0.04) | - |
| EPS - Diluted | $1.27 | $1.23 | $1.48 | $0.83 | ($0.04) | - |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $232.62M | $412.56M | $343.85M | $294.19M | $119.42M | $99.27M |
| Accounts Receivable | $473.57M | $409.73M | $377.66M | $377.54M | $338.24M | $328.34M |
| Inventory | $471.15M | $388.13M | $274.00M | $224.28M | $183.09M | $158.60M |
| Accounts Payable | $639.83M | $610.78M | $426.51M | $378.76M | $279.25M | $282.91M |
| Current Assets | $1.26B | $1.32B | $1.09B | $994.34M | $710.26M | $657.01M |
| Total Assets | $3.46B | $3.42B | $3.22B | $3.11B | $2.79B | $2.65B |
| Current Liabilities | $829.35M | $780.15M | $618.31M | $565.35M | $459.69M | $434.02M |
| Long-term Debt | $1.15B | $1.10B | $1.06B | $1.06B | $1.06B | $1.12B |
| Total Liabilities | $2.13B | $2.02B | $1.80B | $1.73B | $1.62B | $1.63B |
| Stockholders' Equity | $1.33B | $1.40B | $1.42B | $1.39B | $1.18B | $1.02B |
| Retained Earnings | $876.92M | $669.34M | $457.51M | $190.42M | $39.87M | ($100.03M) |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $258.45M | $323.39M | $371.30M | $267.55M | $208.57M | $127.39M |
| Investing Cash Flow | ($161.08M) | ($36.47M) | ($56.51M) | ($108.05M) | ($111.54M) | ($26.33M) |
| Financing Cash Flow | ($277.31M) | ($218.21M) | ($265.13M) | $15.27M | ($76.87M) | ($68.85M) |
| CapEx | $41.31M | $35.61M | $41.87M | $35.36M | $25.63M | $26.88M |
| Free Cash Flow | $217.14M | $287.79M | $329.43M | $232.19M | $182.94M | $100.52M |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 19.3% | 20.3% | 22.8% | 22.0% | 22.7% | 22.5% |
| Operating margin | 6.0% | 6.4% | 7.3% | 6.1% | 5.5% | 3.7% |
| EBITDA margin | 7.2% | 7.7% | 8.7% | 7.6% | 7.4% | 6.0% |
| Net margin | 3.7% | 4.2% | 6.2% | 3.8% | 4.1% | -0.3% |
| Free cash flow margin | 3.8% | 5.8% | 7.7% | 5.9% | 5.3% | 3.3% |
| FCF / Net income | 1.05 | 1.36 | 1.23 | 1.54 | 1.31 | -12.45 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 12.1% | 12.6% | 14.1% | 14.4% | 15.3% | 16.5% |
| Effective tax rate | 26.6% | 25.3% | 25.5% | 26.8% | -20.1% | - |
| Return on assets | 6.0% | 6.2% | 8.3% | 4.8% | 5.0% | -0.3% |
| Return on equity | 15.7% | 15.1% | 18.8% | 10.9% | 11.9% | -0.8% |
| Return on invested capital | 10.0% | 9.6% | 9.5% | 7.2% | 8.5% | 4.1% |
| Liquidity | ||||||
| Current ratio | 1.53 | 1.70 | 1.77 | 1.76 | 1.55 | 1.51 |
| Quick ratio | 0.96 | 1.20 | 1.33 | 1.36 | 1.15 | 1.15 |
| Cash ratio | 0.28 | 0.53 | 0.56 | 0.52 | 0.26 | 0.23 |
| Leverage | ||||||
| Debt / Equity | 0.87 | 0.79 | 0.74 | 0.76 | 0.90 | 1.10 |
| Debt / Assets | 0.33 | 0.32 | 0.33 | 0.34 | 0.38 | 0.42 |
| Debt / EBITDA | 2.85 | 2.89 | 2.83 | 3.52 | 4.17 | 6.12 |
| Interest coverage | 6.2x | 6.6x | 6.1x | 4.5x | 2.8x | 1.0x |
| Equity multiplier | 2.61 | 2.44 | 2.26 | 2.25 | 2.37 | 2.61 |
| Liabilities / Assets | 0.62 | 0.59 | 0.56 | 0.55 | 0.58 | 0.62 |
| Efficiency | ||||||
| Asset turnover | 1.63 | 1.46 | 1.34 | 1.27 | 1.23 | 1.15 |
| Inventory turnover | 9.68 | 8.88 | 12.12 | 13.72 | 14.52 | 14.82 |
| Days sales outstanding | 31d | 30d | 32d | 35d | 36d | 40d |
| Days inventory outstanding | 38d | 41d | 30d | 27d | 25d | 25d |
| Days payable outstanding | 51d | 65d | 47d | 45d | 38d | 44d |
| Cash conversion cycle | 17d | 6d | 15d | 17d | 23d | 20d |
| Valuation | ||||||
| P / E | 25.1x | 18.9x | 22.8x | 36.3x | - | - |
| P / B | 3.9x | 2.9x | 4.3x | 4.0x | 4.4x | - |
| P / S | 0.9x | 0.8x | 1.4x | 1.4x | 1.5x | - |
| EV / EBITDA | 15.1x | 12.3x | 18.2x | 20.8x | 24.0x | - |
| Growth | ||||||
| Revenue growth (YoY) | 13.0% | 16.2% | 9.1% | 14.7% | 13.4% | 31.3% |
| Revenue CAGR (3y) | 12.7% | 13.3% | 12.4% | 19.5% | 54.3% | - |
| Revenue CAGR (5y) | 13.3% | 16.7% | 35.7% | - | - | - |
| Gross profit growth (YoY) | 7.4% | 3.2% | 13.2% | 11.2% | 14.3% | 33.0% |
| Operating income growth (YoY) | 5.0% | 2.3% | 31.0% | 25.9% | 72.3% | - |
| Net income growth (YoY) | -2.0% | -20.7% | 77.4% | 7.6% | - | 89.4% |
| EPS growth (YoY) | 3.3% | -16.9% | 78.3% | - | - | - |
| EPS CAGR (3y) | 15.2% | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | -24.5% | -12.6% | 41.9% | 26.9% | 82.0% | 592.7% |
| FCF CAGR (5y) | 16.7% | 81.8% | - | - | - | - |
| Book value growth (YoY) | -5.5% | -1.2% | 2.6% | 17.9% | 15.8% | 12.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$5.56B totalReportable Segment$5.56B · 100.0%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
2.50
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
5/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✗Long-term debt decreased
- ✗Current ratio improved
- ✓No share dilution
- ✗Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Services-Home Health Care Services
Comparing Option Care Health against the 5 most active filers in the same SIC group.